Santarus is adding the cholesterol drug Fenoglide to its portfolio of two prescription products, Glumetza and Cycloset, both of which are geared to patients with type 2 diabetes.

Santarus is adding the cholesterol drug Fenoglide to its portfolio of two prescription products, Glumetza and Cycloset, both of which are geared to patients with type 2 diabetes.

While many San Diego companies were taking it slow in the weeks leading up to 2012, Carmel Valley-based biopharmaceutical firm Santarus Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129